Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt issuances

Cumberland Pharmaceuticals (CPIX) Shares Repurchased (2016 - 2026)

Cumberland Pharmaceuticals' Shares Repurchased history spans 16 years, with the latest figure at $10439.0 for Q3 2025.

On a quarterly basis, Shares Repurchased fell 89.44% to $10439.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $263478.0, a 54.5% decrease, with the full-year FY2025 number at $263478.0, down 54.5% from a year prior.
Shares Repurchased hit $10439.0 in Q3 2025 for Cumberland Pharmaceuticals, up from $7171.0 in the prior quarter.
Over the last five years, Shares Repurchased for CPIX hit a ceiling of $580130.0 in Q1 2022 and a floor of $7171.0 in Q2 2025.
Historically, Shares Repurchased has averaged $211734.3 across 5 years, with a median of $189659.0 in 2022.
Biggest five-year swings in Shares Repurchased: surged 168.56% in 2023 and later tumbled 94.66% in 2025.
Tracing CPIX's Shares Repurchased over 5 years: stood at $361192.0 in 2021, then plummeted by 47.49% to $189659.0 in 2022, then decreased by 0.36% to $188970.0 in 2023, then tumbled by 47.94% to $98383.0 in 2024, then crashed by 89.39% to $10439.0 in 2025.
Business Quant data shows Shares Repurchased for CPIX at $10439.0 in Q3 2025, $7171.0 in Q2 2025, and $245868.0 in Q1 2025.